Catalyst Wire Dossier Catalyst Wire Dossier

Etodolac Extended Release Tablets USP 600 mg

Etodolac · IPCA Laboratories Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Etodolac Extended Release Tablets USP 600 mg, covering 2013-04-10 to 2013-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition [Phase 1]

See pricing